Astrana Health Past Earnings Performance

Past criteria checks 2/6

Astrana Health has been growing earnings at an average annual rate of 7.1%, while the Healthcare industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 25.5% per year. Astrana Health's return on equity is 7.6%, and it has net margins of 1.6%.

Key information

7.12%

Earnings growth rate

2.27%

EPS growth rate

Healthcare Industry Growth15.67%
Revenue growth rate25.48%
Return on equity7.59%
Net Margin1.56%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Astrana Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:3AM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 252,251351590
31 Dec 242,035431540
30 Sep 241,722621500
30 Jun 241,592681420
31 Mar 241,454621300
31 Dec 231,387611130
30 Sep 231,32845990
30 Jun 231,29746910
31 Mar 231,21845870
31 Dec 221,14445780
30 Sep 221,04558670
30 Jun 2295569680
31 Mar 2286170620
31 Dec 2177469620
30 Sep 2175670550
30 Jun 2170953490
31 Mar 2169847470
31 Dec 2068738490
30 Sep 2068935510
30 Jun 2066522430
31 Mar 2063018410
31 Dec 1956114400
30 Sep 194884440
30 Jun 1949910450
31 Mar 194929460
31 Dec 1852011470
30 Sep 1850628420
30 Jun 1843624380
31 Mar 1839524330
31 Dec 1735626260
30 Sep 1733613220
30 Jun 1732311230
31 Mar 1731712220
31 Dec 1630611210
31 Dec 1531313270
31 Dec 14134-1360

Quality Earnings: 3AM has high quality earnings.

Growing Profit Margin: 3AM's current net profit margins (1.6%) are lower than last year (4.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 3AM's earnings have grown by 7.1% per year over the past 5 years.

Accelerating Growth: 3AM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3AM had negative earnings growth (-43.9%) over the past year, making it difficult to compare to the Healthcare industry average (-8.2%).


Return on Equity

High ROE: 3AM's Return on Equity (7.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 19:33
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Astrana Health, Inc. is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hua HaBaird
Andrew MokBarclays
Sarah JamesBarclays